Fluorine in PDB 5ohj: Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.
Enzymatic activity of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.
All present enzymatic activity of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.:
3.1.4.53;
Protein crystallography data
The structure of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor., PDB code: 5ohj
was solved by
A.Rizzi,
L.Carzaniga,
E.Armani,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
29.61 /
1.60
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
55.270,
55.730,
225.560,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
18.4 /
21.2
|
Other elements in 5ohj:
The structure of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor. also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.
(pdb code 5ohj). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor., PDB code: 5ohj:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 5ohj
Go back to
Fluorine Binding Sites List in 5ohj
Fluorine binding site 1 out
of 4 in the Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F801
b:18.4
occ:1.00
|
F
|
A:9VE801
|
0.0
|
18.4
|
1.0
|
C
|
A:9VE801
|
1.3
|
14.1
|
1.0
|
O
|
A:9VE801
|
2.2
|
13.6
|
1.0
|
F1
|
A:9VE801
|
2.2
|
16.5
|
1.0
|
C1
|
A:9VE801
|
2.9
|
16.0
|
1.0
|
C31
|
A:9VE801
|
3.0
|
15.4
|
1.0
|
ND2
|
A:ASN567
|
3.2
|
10.6
|
1.0
|
C
|
A:TRP578
|
3.2
|
12.1
|
1.0
|
CB
|
A:TRP578
|
3.4
|
11.5
|
1.0
|
O
|
A:TRP578
|
3.4
|
12.1
|
1.0
|
N
|
A:THR579
|
3.4
|
11.4
|
1.0
|
CA
|
A:THR579
|
3.6
|
12.9
|
1.0
|
OG1
|
A:THR579
|
3.8
|
12.4
|
1.0
|
CB
|
A:ASN567
|
3.9
|
11.5
|
1.0
|
CG2
|
A:ILE582
|
3.9
|
13.0
|
1.0
|
CA
|
A:TRP578
|
3.9
|
11.6
|
1.0
|
CG
|
A:ASN567
|
4.0
|
11.3
|
1.0
|
CE2
|
A:TYR405
|
4.2
|
10.3
|
1.0
|
C2
|
A:9VE801
|
4.2
|
15.3
|
1.0
|
C30
|
A:9VE801
|
4.4
|
14.7
|
1.0
|
CB
|
A:THR579
|
4.4
|
12.6
|
1.0
|
CB
|
A:ILE582
|
4.4
|
12.5
|
1.0
|
O
|
A:TYR575
|
4.6
|
12.1
|
1.0
|
CG
|
A:TRP578
|
4.7
|
11.7
|
1.0
|
CE1
|
A:TYR575
|
4.7
|
11.2
|
1.0
|
O1
|
A:9VE801
|
4.7
|
16.2
|
1.0
|
CD1
|
A:TYR575
|
4.7
|
11.5
|
1.0
|
C
|
A:THR579
|
4.9
|
13.7
|
1.0
|
OH
|
A:TYR405
|
4.9
|
10.5
|
1.0
|
OE1
|
A:GLN615
|
4.9
|
12.1
|
1.0
|
CD2
|
A:TYR405
|
4.9
|
10.4
|
1.0
|
CZ
|
A:TYR405
|
4.9
|
9.8
|
1.0
|
NE2
|
A:GLN615
|
5.0
|
12.4
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 5ohj
Go back to
Fluorine Binding Sites List in 5ohj
Fluorine binding site 2 out
of 4 in the Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F801
b:16.5
occ:1.00
|
F1
|
A:9VE801
|
0.0
|
16.5
|
1.0
|
C
|
A:9VE801
|
1.3
|
14.1
|
1.0
|
F
|
A:9VE801
|
2.2
|
18.4
|
1.0
|
O
|
A:9VE801
|
2.3
|
13.6
|
1.0
|
C1
|
A:9VE801
|
2.8
|
16.0
|
1.0
|
C31
|
A:9VE801
|
3.0
|
15.4
|
1.0
|
CB
|
A:ASN567
|
3.3
|
11.5
|
1.0
|
CE1
|
A:TYR575
|
3.4
|
11.2
|
1.0
|
CG
|
A:PRO568
|
3.6
|
10.6
|
1.0
|
ND2
|
A:ASN567
|
3.7
|
10.6
|
1.0
|
CD
|
A:PRO568
|
3.7
|
10.3
|
1.0
|
CE2
|
A:PHE618
|
3.7
|
13.4
|
1.0
|
OE1
|
A:GLN615
|
3.7
|
12.1
|
1.0
|
CD1
|
A:TYR575
|
3.9
|
11.5
|
1.0
|
CG
|
A:ASN567
|
4.1
|
11.3
|
1.0
|
C2
|
A:9VE801
|
4.1
|
15.3
|
1.0
|
N
|
A:PRO568
|
4.2
|
10.6
|
1.0
|
C30
|
A:9VE801
|
4.2
|
14.7
|
1.0
|
OG1
|
A:THR579
|
4.3
|
12.4
|
1.0
|
O
|
A:HOH759
|
4.3
|
14.0
|
1.0
|
CD2
|
A:PHE618
|
4.4
|
14.4
|
1.0
|
CA
|
A:ASN567
|
4.4
|
10.3
|
1.0
|
CZ
|
A:TYR575
|
4.5
|
12.0
|
1.0
|
C
|
A:ASN567
|
4.5
|
10.8
|
1.0
|
CD
|
A:GLN615
|
4.5
|
12.1
|
1.0
|
O1
|
A:9VE801
|
4.5
|
16.2
|
1.0
|
NE2
|
A:GLN615
|
4.7
|
12.4
|
1.0
|
CZ
|
A:PHE618
|
4.7
|
13.1
|
1.0
|
CB
|
A:TRP578
|
4.8
|
11.5
|
1.0
|
OH
|
A:TYR575
|
4.8
|
12.9
|
1.0
|
CB
|
A:PRO568
|
4.8
|
12.5
|
1.0
|
CA
|
A:PRO568
|
4.9
|
11.4
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 5ohj
Go back to
Fluorine Binding Sites List in 5ohj
Fluorine binding site 3 out
of 4 in the Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:20.1
occ:1.00
|
F
|
B:9VE801
|
0.0
|
20.1
|
1.0
|
C
|
B:9VE801
|
1.3
|
19.0
|
1.0
|
O
|
B:9VE801
|
2.1
|
17.6
|
1.0
|
F1
|
B:9VE801
|
2.3
|
19.3
|
1.0
|
C1
|
B:9VE801
|
2.8
|
18.1
|
1.0
|
C31
|
B:9VE801
|
3.0
|
17.6
|
1.0
|
C
|
B:TRP578
|
3.2
|
14.2
|
1.0
|
O
|
B:TRP578
|
3.2
|
12.9
|
1.0
|
ND2
|
B:ASN567
|
3.3
|
13.1
|
1.0
|
CB
|
B:TRP578
|
3.4
|
13.5
|
1.0
|
N
|
B:THR579
|
3.4
|
14.3
|
1.0
|
CA
|
B:THR579
|
3.6
|
14.7
|
1.0
|
CG2
|
B:ILE582
|
3.8
|
14.3
|
1.0
|
OG1
|
B:THR579
|
3.9
|
13.0
|
1.0
|
CA
|
B:TRP578
|
3.9
|
13.7
|
1.0
|
CB
|
B:ASN567
|
4.0
|
12.6
|
1.0
|
C2
|
B:9VE801
|
4.1
|
18.8
|
1.0
|
CG
|
B:ASN567
|
4.1
|
13.4
|
1.0
|
CE2
|
B:TYR405
|
4.2
|
13.8
|
1.0
|
CB
|
B:ILE582
|
4.3
|
14.0
|
1.0
|
C30
|
B:9VE801
|
4.3
|
17.5
|
1.0
|
CB
|
B:THR579
|
4.4
|
14.7
|
1.0
|
O1
|
B:9VE801
|
4.6
|
19.0
|
1.0
|
CE1
|
B:TYR575
|
4.7
|
13.6
|
1.0
|
CG
|
B:TRP578
|
4.7
|
13.8
|
1.0
|
O
|
B:TYR575
|
4.7
|
14.5
|
1.0
|
CD1
|
B:TYR575
|
4.8
|
13.6
|
1.0
|
C
|
B:THR579
|
4.8
|
16.0
|
1.0
|
OE1
|
B:GLN615
|
4.9
|
13.3
|
1.0
|
OH
|
B:TYR405
|
4.9
|
13.5
|
1.0
|
NE2
|
B:GLN615
|
4.9
|
13.6
|
1.0
|
CD2
|
B:TYR405
|
4.9
|
14.3
|
1.0
|
CZ
|
B:TYR405
|
4.9
|
13.4
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 5ohj
Go back to
Fluorine Binding Sites List in 5ohj
Fluorine binding site 4 out
of 4 in the Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor.
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Human Phosphodiesterase 4B Catalytic Domain in Complex with A Pyrrolidinyl Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F801
b:19.3
occ:1.00
|
F1
|
B:9VE801
|
0.0
|
19.3
|
1.0
|
C
|
B:9VE801
|
1.4
|
19.0
|
1.0
|
O
|
B:9VE801
|
2.2
|
17.6
|
1.0
|
F
|
B:9VE801
|
2.3
|
20.1
|
1.0
|
C1
|
B:9VE801
|
2.8
|
18.1
|
1.0
|
C31
|
B:9VE801
|
2.9
|
17.6
|
1.0
|
CB
|
B:ASN567
|
3.3
|
12.6
|
1.0
|
CE1
|
B:TYR575
|
3.4
|
13.6
|
1.0
|
CG
|
B:PRO568
|
3.5
|
11.6
|
1.0
|
OE1
|
B:GLN615
|
3.6
|
13.3
|
1.0
|
CE2
|
B:PHE618
|
3.7
|
13.8
|
1.0
|
CD
|
B:PRO568
|
3.7
|
11.3
|
1.0
|
ND2
|
B:ASN567
|
3.7
|
13.1
|
1.0
|
CD1
|
B:TYR575
|
3.9
|
13.6
|
1.0
|
C2
|
B:9VE801
|
4.0
|
18.8
|
1.0
|
CG
|
B:ASN567
|
4.1
|
13.4
|
1.0
|
C30
|
B:9VE801
|
4.2
|
17.5
|
1.0
|
N
|
B:PRO568
|
4.2
|
11.4
|
1.0
|
OG1
|
B:THR579
|
4.3
|
13.0
|
1.0
|
CD2
|
B:PHE618
|
4.3
|
13.8
|
1.0
|
CD
|
B:GLN615
|
4.4
|
13.5
|
1.0
|
CA
|
B:ASN567
|
4.5
|
11.9
|
1.0
|
O1
|
B:9VE801
|
4.5
|
19.0
|
1.0
|
CZ
|
B:TYR575
|
4.5
|
13.3
|
1.0
|
O
|
B:HOH708
|
4.5
|
15.4
|
1.0
|
C
|
B:ASN567
|
4.5
|
11.6
|
1.0
|
NE2
|
B:GLN615
|
4.6
|
13.6
|
1.0
|
CZ
|
B:PHE618
|
4.7
|
14.1
|
1.0
|
CB
|
B:TRP578
|
4.7
|
13.5
|
1.0
|
OH
|
B:TYR575
|
4.8
|
14.2
|
1.0
|
CB
|
B:PRO568
|
4.8
|
11.9
|
1.0
|
CA
|
B:PRO568
|
4.9
|
11.6
|
1.0
|
|
Reference:
L.Carzaniga,
G.Amari,
A.Rizzi,
C.Capaldi,
R.De Fanti,
E.Ghidini,
G.Villetti,
C.Carnini,
N.Moretto,
F.Facchinetti,
P.Caruso,
G.Marchini,
L.Battipaglia,
R.Patacchini,
V.Cenacchi,
R.Volta,
F.Amadei,
A.Pappani,
S.Capacchi,
V.Bagnacani,
M.Delcanale,
P.Puccini,
S.Catinella,
M.Civelli,
E.Armani.
Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives As Inhaled PDE4 Inhibitors For Respiratory Diseases. J. Med. Chem. V. 60 10026 2017.
ISSN: ISSN 1520-4804
PubMed: 29200281
DOI: 10.1021/ACS.JMEDCHEM.7B01044
Page generated: Thu Aug 1 12:24:57 2024
|